How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?

@article{Kerola2012HowEI,
  title={How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?},
  author={A. Kerola and M. Kauppi and T. Kerola and T. Nieminen},
  journal={Annals of the Rheumatic Diseases},
  year={2012},
  volume={71},
  pages={1606 - 1615}
}
Rheumatoid arthritis (RA) is a chronic inflammatory disease which is associated with an increased cardiovascular (CV) burden. Whether the risk is already present at the time of RA diagnosis remains a key area of debate. The aim of this review was to evaluate the existence of both subclinical CV changes, including endothelial dysfunction and atherosclerosis, CV risk factors, as well as CV disease manifestations such as coronary heart disease, myocardial infarction, congestive heart failure and… Expand
The Characteristics of Chronic Heart Failure in Rheumatoid Arthritis
The evolution of early arthritis and cardiovascular risk
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review
Cardiovascular risk in rheumatoid arthritis.
Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 113 REFERENCES
How early is the atherosclerotic risk in rheumatoid arthritis?
Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients.
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
...
1
2
3
4
5
...